The Form 4 filing, an SEC report of changes in an insider's stock ownership, was filed on October 14, 2026. Both sales took place on October 12, 2026.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 15,272 |
| Price | $72.04 |
| Total Transaction Value | $1,100,182.64 |
| Insider | |
| Ticker Symbol | MRX |
| Company | Marex Group Ltd |
| Insider Name | Van Den Born Simon |
| Insider Title | President |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 1,455,076 |
| Position Size Change | 1.04% |
| Filing | |
| Filing Date | 2026-10-14 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of MRX shares, reported with transaction code S. The filing lists two sales by Van Den Born Simon, Marex Group Ltd's president.
What was the average price of the transaction?
The average sale price was $72.04 per share, rounded to the nearest cent. This average covers both reported sales. A separate price for each sale was not available.
How did this transaction affect the insider's holdings?
He sold 15,272 shares and reported owning 1,455,076 shares afterward. The shares sold were 1.04% of his shares held before the sales.
What's the total transaction value?
The total value was $1,100,182.64 for the two transactions combined. This covers all 15,272 shares reported as sold.
Are there any special circumstances around this transaction?
A Rule 10b5-1 trading-plan reference was identified for this filing. Such plans set trading instructions in advance. The reference alone does not show which trades it covers.
No footnote text was available to confirm whether one sale or both fell under a plan. The plan's start date and terms are unknown. The reference also does not show whether the trades met the rule's requirements.
For research purposes only; not investment advice.